| Execution period | 36 months |
|---|
NSE filing, NSE: TATVA. Summary written from the filing by ALFA Finder's alert engine.
Tatva Chintan Pharma Chem Ltd: key numbers
- Share price
- ₹1,661.80
- Market cap
- ₹3,887 Cr
- Revenue (annual)
- ₹505.9 Cr
- Net profit (annual)
- ₹42.05 Cr
- P/E (TTM)
- 61.8×Sector 33.6×
- Promoter holding
- 72.02%+0.00% QoQ
- FII holding
- 4.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tatva Chintan Pharma Chem Ltd
All →Tatva Chintan Pharma Chem Investor Presentation: Key Takeaways
Tatva Chintan reported record quarterly revenue of ₹2,173 Mn for Q2 FY27, up 76% YoY, driven by strong SDA demand. EBITDA margins remained flat at 19% due to high solvent costs and freight spikes.
Tatva Chintan Pharma Chem Q2 FY27 Results: Net Profit ₹21.5 Cr, Up 117.2% YoY
Tatva Chintan Pharma Chem Ltd reported revenue from operations of ₹217.3 Cr (+76.0% YoY) and net profit of ₹21.5 Cr (+117.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.5 Cr · +117.2% YoY
Tatva Chintan Pharma Chem Other Announcement
The company has filed its quarterly shareholding pattern as per SEBI regulations. This routine disclosure provides details on the current shareholding structure.
Tatva Chintan Pharma Chem Board Meeting Date
Tatva Chintan Pharma Chem has scheduled a Board meeting for 19 October 2026 to consider Q1 FY27 financial results. The trading window will remain closed until 48 hours after results are published.
Tatva Chintan Pharma Chem Annual General Meeting
The company held its 30th Annual General Meeting on September 25, 2026. Shareholders considered and approved items including financial statements and director re-appointments.
Tatva Chintan Pharma Chem Credit Rating
CRISIL Ratings upgraded Tatva Chintan's long-term bank facilities to CRISIL A-/Stable and short-term facilities to CRISIL A2+. This upgrade reflects the company's improved credit profile.
Other management change announcements
All →Naperol Investments Management Change
Naperol Investments disclosed that non-executive director Rajiv Arora resigned, effective close of business on November 2, 2026, citing family and personal reasons. The filing includes the Regulation 30 annexure and his resignation letter.
McNally Bharat Engineering Company Management Change
McNally Bharat Engineering appointed Pradumn Kumar Dixit as Additional Non-Executive Non-Independent Director by circular resolution on 2 November 2026. Shareholder approval is needed within three months.
Fractal Analytics Management Change
Fractal Analytics reported senior management retirements: Rasesh Shah effective November 2, 2026, and Biju Dominic effective November 13, 2026. No financial impact is stated.
Walchandnagar Industries Management Change
Walchandnagar Industries appointed Chandra Bhan Yadav as Interim Chief Financial Officer and KMP effective November 2, 2026. The board also amended its fair disclosure policy.
KEC International Management Change
KEC International appointed Mr. Anant Vardhan Goenka as Additional Director (Non-Executive, Non-Independent) effective November 2, 2026. Shareholder approval is required within three months.
EPack Prefab Technologies Management Change
EPack Prefab appointed Ms. Khushboo Mishra as Company Secretary and Compliance Officer, effective 2 November 2026. She has over 13 years of experience in corporate governance and capital markets.